117 related articles for article (PubMed ID: 1483923)
1. Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma.
Yana I; Nakamura T; Shin E; Karakawa K; Kurahashi H; Kurita Y; Kobayashi T; Mori T; Nishisho I; Takai S
Jpn J Cancer Res; 1992 Nov; 83(11):1113-6. PubMed ID: 1483923
[TBL] [Abstract][Full Text] [Related]
2. Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas.
Herfarth KK; Wick MR; Marshall HN; Gartner E; Lum S; Moley JF
Genes Chromosomes Cancer; 1997 Sep; 20(1):24-9. PubMed ID: 9290950
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
[TBL] [Abstract][Full Text] [Related]
4. Loss of genes on chromosome 22 in medullary thyroid carcinoma and pheochromocytoma.
Takai S; Tateishi H; Nishisho I; Miki T; Motomura K; Miyauchi A; Kato M; Ikeuchi T; Yamamoto K; Okazaki M
Jpn J Cancer Res; 1987 Sep; 78(9):894-8. PubMed ID: 2889715
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers.
Moley JF; Brother MB; Wells SA; Spengler BA; Biedler JL; Brodeur GM
Cancer Res; 1991 Mar; 51(6):1596-9. PubMed ID: 1998949
[TBL] [Abstract][Full Text] [Related]
7. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.
Mulligan LM; Gardner E; Smith BA; Mathew CG; Ponder BA
Genes Chromosomes Cancer; 1993 Mar; 6(3):166-77. PubMed ID: 7682102
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of 17p, but no p53 mutations or protein overexpression in benign and malignant pheochromocytomas.
Petri BJ; Speel EJ; Korpershoek E; Claessen SM; van Nederveen FH; Giesen V; Dannenberg H; van der Harst E; Dinjens WN; de Krijger RR
Mod Pathol; 2008 Apr; 21(4):407-13. PubMed ID: 18223555
[TBL] [Abstract][Full Text] [Related]
9. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on the long arm of chromosome 22 in pheochromocytoma.
Tanaka N; Nishisho I; Yamamoto M; Miya A; Shin E; Karakawa K; Fujita S; Kobayashi T; Rouleau GA; Mori T
Genes Chromosomes Cancer; 1992 Nov; 5(4):399-403. PubMed ID: 1283329
[TBL] [Abstract][Full Text] [Related]
11. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
[TBL] [Abstract][Full Text] [Related]
12. Characterization of neuroendocrine tumors in heterozygous mutant MENX rats: a novel model of invasive medullary thyroid carcinoma.
Molatore S; Kügler A; Irmler M; Wiedemann T; Neff F; Feuchtinger A; Beckers J; Robledo M; Roncaroli F; Pellegata NS
Endocr Relat Cancer; 2018 Feb; 25(2):145-162. PubMed ID: 29142006
[TBL] [Abstract][Full Text] [Related]
13. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.
Jimenez C; Habra MA; Huang SC; El-Naggar A; Shapiro SE; Evans DB; Cote G; Gagel RF
J Clin Endocrinol Metab; 2004 Aug; 89(8):4142-5. PubMed ID: 15292360
[TBL] [Abstract][Full Text] [Related]
14. Topographic molecular profile of pheochromocytomas: role of somatic down-regulation of mismatch repair.
Blanes A; Sanchez-Carrillo JJ; Diaz-Cano SJ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1150-8. PubMed ID: 16394087
[TBL] [Abstract][Full Text] [Related]
15. Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine.
Sobol H; Narod SA; Schuffenecker I; Amos C; Ezekowitz RA; Lenoir GM
Henry Ford Hosp Med J; 1989; 37(3-4):109-11. PubMed ID: 2576938
[TBL] [Abstract][Full Text] [Related]
16. Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A.
Okazaki M; Miya A; Tanaka N; Miki T; Yamamoto M; Motomura K; Miyauchi A; Mori T; Takai S
Henry Ford Hosp Med J; 1989; 37(3-4):112-5. PubMed ID: 2576939
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis, management, and pathogenetic studies in medullary thyroid carcinoma syndrome.
Samaan NA; Yang KP; Schultz P; Hickey RC
Henry Ford Hosp Med J; 1989; 37(3-4):132-7. PubMed ID: 2576946
[TBL] [Abstract][Full Text] [Related]
18. Molecular and immunohistochemical analysis of P53 in phaeochromocytoma.
Dahia PL; Aguiar RC; Tsanaclis AM; Bendit I; Bydlowski SP; Abelin NM; Toledo SP
Br J Cancer; 1995 Nov; 72(5):1211-3. PubMed ID: 7577469
[TBL] [Abstract][Full Text] [Related]
19. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?
Shifrin AL; Xenachis C; Fay A; Matulewicz TJ; Kuo YH; Vernick JJ
Surgery; 2009 Dec; 146(6):998-1005. PubMed ID: 19958926
[TBL] [Abstract][Full Text] [Related]
20. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.
Ball DW; Azzoli CG; Baylin SB; Chi D; Dou S; Donis-Keller H; Cumaraswamy A; Borges M; Nelkin BD
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5648-52. PubMed ID: 8390674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
